EP1185212A1 - Membrane a usage medical pour stimuler la formation tissulaire - Google Patents
Membrane a usage medical pour stimuler la formation tissulaireInfo
- Publication number
- EP1185212A1 EP1185212A1 EP00927670A EP00927670A EP1185212A1 EP 1185212 A1 EP1185212 A1 EP 1185212A1 EP 00927670 A EP00927670 A EP 00927670A EP 00927670 A EP00927670 A EP 00927670A EP 1185212 A1 EP1185212 A1 EP 1185212A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- medical
- pulp
- medical membrane
- cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 187
- 230000009772 tissue formation Effects 0.000 title abstract description 3
- 230000004936 stimulating effect Effects 0.000 title 1
- 210000004268 dentin Anatomy 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 24
- 239000011248 coating agent Substances 0.000 claims abstract description 7
- 238000000576 coating method Methods 0.000 claims abstract description 7
- 230000010354 integration Effects 0.000 claims abstract description 6
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 3
- 239000003102 growth factor Substances 0.000 claims abstract description 3
- 239000013543 active substance Substances 0.000 claims abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 16
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 5
- 230000017423 tissue regeneration Effects 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- -1 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 230000002787 reinforcement Effects 0.000 claims description 3
- 239000004568 cement Substances 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 9
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000008733 trauma Effects 0.000 abstract description 2
- 210000003074 dental pulp Anatomy 0.000 abstract 1
- 238000009413 insulation Methods 0.000 abstract 1
- 239000011344 liquid material Substances 0.000 abstract 1
- 239000011343 solid material Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 13
- 230000008929 regeneration Effects 0.000 description 11
- 238000011069 regeneration method Methods 0.000 description 11
- 238000007789 sealing Methods 0.000 description 8
- 230000007547 defect Effects 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- 230000029663 wound healing Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 239000003178 glass ionomer cement Substances 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000010478 bone regeneration Effects 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C5/00—Filling or capping teeth
- A61C5/50—Implements for filling root canals; Methods or instruments for medication of tooth nerve channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
Definitions
- the present invention relates to a medical membrane and a method for applying a medical membrane in dentistry.
- Medical membranes can be used to selectively influence cell types with different growth rates or attachment properties as part of healing processes in the wound area. For example, undesired cell shapes with a higher growth rate are shielded and the colonization of the defect is promoted with cells that regenerate the desired tissue. This process is referred to as controlled tissue regeneration or “guided tissue regeneration.” “Guided bone regeneration” is used when, with the use of membranes, rapidly growing epithelial and connective tissue cells are specifically prevented from colonizing and proliferation in the wound area, and thus slowly growing bone cells the possibility is given to take over the defect healing.
- Such membranes are made from various substances, absorbable from “collagen” or “polylactic / polyglycolide acid polymer” or “copolymer” and non-absorbable from “polytetrafluoroethylene”. Absorbable membranes are left in situ; non-resorbable are removed after they have fulfilled their task.
- This object is achieved with a generic medical membrane according to claim 1.
- This is a membrane which, particularly with regard to its size and nature, allows a pulp opening to be covered in a cavity in the dentin of a tooth. It turns out that by protecting the membrane, the regeneration ability and vitality of the pulse pa is improved. In addition to the direct opening of the pulp, deep dentin wounds are also caused by tangling the small tubules, which place a great strain on the pulp and thus injure the pulp.
- a membrane is preferred which is suitable for
- Sealer or is essentially impervious to cement. Essentially impermeable means that the membrane is impermeable to substances that interfere with pulp and / or dentine regeneration.
- a membrane is preferred which has at least one roughened surface in order to allow the attachment of fibrin threads, the attachment and ingrowth of pulpafibroblasts and other cells.
- the roughened surface is porous and / or network-like.
- the porous and / or mesh-like design of the membrane simultaneously enables molecules or ions to diffuse through the membrane.
- the membrane has a roughened surface, which is preferably porous and / or mesh-like, but on the other hand, to protect the pulp, it is at least impermeable to substances which interfere with pulp regeneration.
- This can e.g. can be achieved with a bilayer design in which impermeability to interfering substances is achieved by forming the membrane material more densely than in the area facing away from the pulp.
- the passage of interfering substances is prevented by a differently structured membrane on the side facing away from the pulp on the side facing the pulp, with a differently structured, especially impermeable
- the membrane must be so impermeable that, at least for a short time, substances that interfere with pulp and dentin regeneration are prevented, so that a tightly sealing, preferably hard-setting coating is possible in situ after application of the membrane.
- the pore or mesh portion of the porous or mesh-like surface of the membrane pad facing the pulp be greater than 20%, preferably greater than 50%.
- the proportion of pores or meshes favors the attachment and the integration of the regenerative cells and thus ensures wound healing, and if the pulp is kept vital, this is preferably followed by hard substance formation which closes the opening of the pulp.
- a particularly good integration of the regenerative cells occurs when the average pore diameter or mesh size is between 0.5 ⁇ m and 200 ⁇ m, preferably around 1 ⁇ m to 100 ⁇ m.
- a membrane is advantageous which shows self-adhesion to the hard tooth substance or adheres to the hard tooth substance by adhesive coating without endangering the pulp, so that the sealing overlayer, which in turn preferably shows adhesion to the hard tooth substance, such as, for example, glass ionomer cements or light-curing glass ionomer cements, does not come into direct or indirect contact with the pulp tissue due to the impermeability of the membrane.
- the medical membrane according to the invention per se or preferably after hard-setting sealing or coating, forms a preferably hard and tight barrier between the pulp opening and the adjacent dental hard substance on the one hand and the restoration built up over the membrane or over the sealed or layered membrane on the other hand, the latter partially or completely replaced the missing tooth structure.
- the impermeability of the membrane which is inherent or achieved by overlaying, ensures that neither substances from the pulp to the restoration nor substances from the restoration to the pulp can get.
- the membrane is therefore sealed per se or after overlaying against the penetration of liquids such as blood, serum or water.
- liquids such as blood, serum or water.
- it is biologically impermeable to cells and microorganisms and, to the extent necessary for biocompatibility, it is chemically impermeable to molecules and ions, which disrupt the regeneration of pulp and dentin.
- the membrane has an area of less than 100 mm, preferably less than 50 mm 2 .
- the medical membranes usually offered in larger units are not only completely unsuitable for covering pulp openings due to the lack of adhesion, thickness and tightness. Also, such membranes cannot be cut to the appropriate size in practice, since the membranes must be very small and also sterile, and thus any cutting and fitting of an unpacked membrane unacceptably increases the risk of infection. The expensive residual membrane pieces should not be picked up for reasons of sterility.
- membrane pads that are less than 3 mm and preferably se less than about 0.5 mm thick. Since thin membranes can have a porosity or density that is sufficient for dentin regeneration, thin membranes are preferably used because of the improved possibility of adaptation.
- the membrane pads are used particularly advantageously within generally concave cavities or fracture surfaces, it is proposed that the membrane pads are preferably round or oval. Such a membrane pad shape can be optimally inserted into the resulting hemispherical cavity after excavating dentine caries.
- a 1 to 2 mm wide, preferably adhesive contact surface on the dental hard tissue surrounding the pulp opening enables the membrane to be placed securely and initially tightly.
- a concave or convex design of the membrane is also advantageous.
- the concave, convex or straight version of the membrane enables a dome-like covering of the pulp opening or a clinging of the membrane to the concavity of the existing cavity.
- the membrane has a carrier film which is biologically and chemically sealed and preferably completely covers the actual membrane pad or at most projects beyond it, the pad-free peripheral part of the carrier film preferably being self-adhesive on the pulp side like a quick dressing.
- This carrier film facilitates the exact positioning of the membrane pad within a cavity in the tooth.
- the carrier film provides a tight, adhesive connection to the tooth structure and also acts as a barrier to the superstructure. Good results can be achieved with membranes which are made from a non-absorbable material, such as, for example, poly-tetrafluoroethylene or preferably titanium. These membranes are not rejected by the body and titanium is suitable for the production of po- structures and, on the other hand, particularly good as an impermeable material.
- membranes made from a resorbable material preferably collagen. These membranes specifically promote the attachment and integration of pulpal fibroblasts and other regenerative cells and in the short term are sufficiently tight for a sealing, hard-setting covering or can be made biologically and chemically tight using a carrier film.
- the membranes are preferably made tear-resistant, but can be cut.
- a soft, cloth-like design makes it freely deformable and adaptable.
- Reinforcements in the membrane body or structural modifications can be achieved, for example, by titanium lamination or another biologically inert material.
- An individual three-dimensional shape can be achieved with membranes that are plastically deformable (lead-dead) thanks to reinforcements, for example.
- the surface of the membrane facing away from the pulp and thus facing the restoration is preferably inert, so that no bond to the restoration is created in order to completely avoid the transfer of shrinkage forces which arise from the polymerizing restoration to the membrane.
- This inertia is preferably achieved by tefionization, hydrophilicity or the use of a non-radical polymer.
- the surface of the membrane facing away from the pulp and thus facing the restoration forms a mechanical or adhesive bond to the restoration in order to ensure a seamless, tight seal of the membrane-supported pulp covering.
- This bond is preferably achieved by interlocking, interlocking, homo- or copolymerization or secondary or primary chemical bonds.
- a dense, mechanical and / or adhesive bond to the hard tooth substance, especially dentine, is preferred. achieved by mechanisms of dentin adhesion, preferably after activation of the adjacent dentin. This can also be achieved by interlocking, interlocking, homo- or copolymerization as well as secondary or primary chemical bonds.
- the inner surface facing the pulp and thus facing away from the restoration is preferably biocompatible, attachment- or cell integration-friendly and sterile.
- growth factors or "bone morphogenetic proteins” can be added to the membrane or pharmacological effects, such as “soft” or “hard” chemotherapeutic effects, can be achieved with the membrane, which are based, among other things, on bacteriostatic or bacteriological effects.
- tissue-stimulating effects which lead to the formation of tertiary dentine, for example, can also be supported by the special design of the membrane.
- Figure la a small round membrane with a round, overlapping carrier film
- Figure lb a small round membrane with a round carrier film, which has the size of the membrane
- FIG. 2a shows a larger round membrane with a round, overlapping carrier film
- FIG. 2b shows a larger round membrane with a round carrier film, which has the size of the membrane
- FIG. 2c shows a larger round membrane without a carrier film
- Figure 3a shows a large round membrane with a round, overlapping carrier film
- Figure 3b shows a large round membrane with a round
- Carrier film that is the size of the membrane is the size of the membrane
- FIG. 4a shows a small square membrane with a square, overlapping carrier film
- FIG. 4b shows a small square membrane with a square carrier film which has the size of the membrane
- FIG. 4c shows a small square membrane without a carrier film
- FIG. 5a an oval membrane with an oval, overlapping carrier film
- FIG. 5b shows an oval membrane with an oval carrier film, which has the size of the membrane
- FIG. 5c shows an oval membrane without a carrier film
- FIG. 6a shows a rectangular membrane with a rectangular, overlapping carrier film
- FIG. 6b shows a rectangular membrane with a rectangular carrier film, which has the size of the membrane
- FIG. 6c shows a rectangular membrane without a carrier film
- FIG. 7 shows a section through a tooth with a cavity on the right
- FIG. 9 shows a section through a tooth with a deeper right-hand cavity
- FIG. 10 shows a three-dimensional representation of a tooth with a cavity and an applied membrane
- FIG. 11 shows a section through a tooth with an applied membrane and inserted filling
- FIG. 12 shows an enlarged detail from FIGS. 11 and
- Figure 13 shows an application instrument for a medical membrane.
- Figures 1 to 6 show different embodiments of membranes 1 to 6, each consisting of a porous membrane part 7 to 12 and a dense carrier film 13 to 18.
- the carrier film 13 to 18 is each larger than the membrane portion 7 to 12, so that it protrudes beyond the edge area of the membrane part 7 to 12.
- the carrier film 13 to 18 can also be the same size as the membrane 7 to 12 ( 13 ⁇ to 18N.
- the function of the carrier film 13 to 18 or 13 'to 18' can also be assumed by coating the membrane in situ , after the membrane has been applied without a carrier film 7 to 12 'primarily adhering to the dentine area surrounding the hard tooth substance.
- FIGS. 1 to 6 are only exemplary embodiments for frequently used forms. Depending on the application, other forms of medical membranes with and without a carrier film or with and without an overlay can also be used.
- FIGS. 7 to 9 show a cavity 19 on a tooth 20 which cuts the pulp 22 in the region 21.
- This area surrounding the open pulp serves as a surface for supporting one of the membranes 1 to 6.
- FIG. 8 shows another cavity 24 on a tooth 25 through which the left branch of the pulp 26 is cut.
- This cavity 24 is also designed in such a way that an at least annular contact surface 28 made of dentine remains around the cutting area 27 of the pulp 26.
- FIG. 9 shows a pulp 30 of a tooth 31 cut laterally through a cavity 29.
- the cut surface 32 between the cavity 29 and the pulp 30 lies in a vertical plane, with an at least annular contact surface 34 made of dentine also being provided around the cut region 33.
- the contact surface formed around the cut pulp can also lie obliquely in the tooth and will be designed differently depending on the situation. Therefore, there are various prefabricated, sterile packaged membrane pads 1 to 6, which are shaped differently so that they can be used in a wide variety of situations.
- the membrane part 7 is supported on an edge between the cavity 35 and the pulp 38 recognizable.
- the carrier film 13 lies above the membrane part 7. It is designed such that it can be pressed against the lower side of the cavity 35 and ensures a seal between the filling 40 and the pulp 38. What is important here is the sealing of the defect edges by a suitable adaptation of the edges of the membrane pad 1, so that the lateral penetration of undesirable substances, for example when overlaying with a hard-setting sealant adhering to the hard tooth substance, such as a light-curing glass ionomer cement or during the restoration of the Defective tooth structure 40 is prevented.
- the sectional drawing in FIG. 12 shows the tooth 36 shown in FIG. 10 with a membrane pad placed thereon, which is constructed according to the bilayer principle and has no carrier film. Sealing takes place within the cavity 35 primarily through the membrane in the area of the dentin that surrounds the pulp opening.
- the membrane is covered in situ with a light-curing glass ionomer cement 39 which is self-adhering to the dentin of the cavity 35 and light-curing.
- the tooth structure defect is supplemented with the restoration 40, which is imperative adhesive and dense.
- FIG. 13 shows a device 40 for applying a medical membrane 1 in a dentin cavity 41 of a tooth 42, which cuts the pulp 43.
- the device 40 comprises a handle 44, to which a fit 45 can be attached and removed.
- the fit 45 preferably has a shape corresponding to the cavity, for example spherical or flat, in order to allow the medical membrane to be pressed on, so that there is no marginal gap and an overlay with, for example, light-curing glass ionomer cement is possible.
- the fitting 45 of a material such as composite, ceramic or plastic ⁇ material remaining after hardening in the cavity and becomes a part of the filling.
- the fit 45 is attached to the handle 44 of the device 40 such that it is easy for the surgeon to put on and take off.
- the desired diameter of the pulp pads 1 to 6 ranges between 1 mm and 10 mm, depending on the size of the cut surface of the pulp or the cavity. For a sufficient circular seal, an approx. 1 to 2 mm wide zone around the open pulp is required. This is to prevent any contact of the open pulp in the marginal area with foreign and toxic materials a priori.
- the membranes used are with the
- the membrane pad can be left in situ indefinitely and thus becomes part of the underfill.
- the lower side of the pulp pad corresponds to the structure of known medical membranes, an average pore diameter between 1 ⁇ m and 100 ⁇ m and a pore fraction of over 50% being preferred. This pore diameter offers the regenerative cells and extracellular substances such.
- Successful treatment depends on whether the work is done in a sterile manner, that is to say without germ contamination for the pulp, and whether the pulp is not exposed to filling materials or microorganisms penetrating from the outside except for the sterile membrane. It is also important to ensure that the porous The membrane part is absolutely close to the dentin. Depending on the cavity, the membrane can be placed flat on the pulp or as a convex or concave membrane part.
- a membrane according to the invention is preferably sterile packed in order to allow sterile working.
- the membrane pads described are of the greatest importance for medical dental treatment, since no primary wound healing has been achieved so far with pulp openings, but instead, by layering Ca (OH) 2 , necrosis that causes the pulp in the underlying pulp tissue is caused, under whose "protection" Tertiary dentine can then develop as part of an inflammatory reaction.
- This is only possible in young patients with a high willingness to regenerate pulp. Since the pulp has no collateral circulation and is only capable of limited defense, larger wound cross-sections exceed the ability to regenerate. In the elderly, for whom the number of dentin-forming stem cells is only low, success has rarely been expected.
- the membrane pads according to the invention offer ideal conditions in the tooth interior for primary wound healing of the opened pulp.
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dentistry (AREA)
- Materials For Medical Uses (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Dental Preparations (AREA)
Abstract
La membrane pulpaire dentaire sert à recouvrir de manière stérile et étanche la pulpe ouverte et/ou partiellement résectée, dans une plaie profonde due à un traumatisme ou résultant d'une mesure de restauration. Selon l'invention, cette membrane pulpaire est biocompatible au moins sur le côté qui fait face à la pulpe et s'utilise en raison de sa composition, de sa structure et de la texture superficielle pour favoriser l'accumulation cellulaire, l'intégration cellulaire et la régénération tissulaire, qui sont en outre éventuellement stimulées par des facteurs de croissance et/ou des principes actifs bactériostatiques ou bactéricides. Cette membrane pulpaire est auto-adhésive ou adhésive sur la substance dure de la dent, qui délimite l'ouverture de la pulpe, de manière à assurer une étanchéité hermétique. Ladite membrane est auto-adhésive ou adhésive sur le côté opposé à la pulpe, de manière à être imperméable aux substances solides ou liquides et aux cellules, voir à avoir un effet isolant, afin de permettre l'application d'un revêtement suffisamment imperméable, adhérant à la substance dure de la dent, de préférence un revêtement à prise ferme. Cette membrane fait de préférence moins de 100 mm2 de superficie et moins de 3 mm d'épaisseur. Elle est préfabriquée dans différents formats, sous forme de bloc membranaire et est conditionnée de manière stérile.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19926438 | 1999-06-10 | ||
DE19926438 | 1999-06-10 | ||
DE19948787A DE19948787A1 (de) | 1999-06-10 | 1999-10-10 | Medizinische Membran zur Anregung der Gewebebildung |
DE19948787 | 1999-10-10 | ||
PCT/IB2000/000730 WO2000076418A1 (fr) | 1999-06-10 | 2000-05-31 | Membrane a usage medical pour stimuler la formation tissulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1185212A1 true EP1185212A1 (fr) | 2002-03-13 |
Family
ID=26053719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00927670A Withdrawn EP1185212A1 (fr) | 1999-06-10 | 2000-05-31 | Membrane a usage medical pour stimuler la formation tissulaire |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1185212A1 (fr) |
JP (1) | JP2003501201A (fr) |
AU (1) | AU4605500A (fr) |
CA (1) | CA2376328A1 (fr) |
WO (1) | WO2000076418A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4056837B2 (ja) * | 2002-09-19 | 2008-03-05 | 株式会社ジーシー | う蝕リスク検査方法 |
KR101370023B1 (ko) * | 2012-04-06 | 2014-03-06 | 서울대학교산학협력단 | 합성고분자 나노섬유메시와 mta를 포함하는 치수질환 치료용 조성물 |
KR101509322B1 (ko) * | 2013-07-31 | 2015-04-07 | 전북대학교산학협력단 | 치아 임플란트용 차폐막 및 그 제조방법 |
WO2015037945A1 (fr) * | 2013-09-13 | 2015-03-19 | 서울대학교산학협력단 | Composition pharmaceutique pour thérapie de régénération de la pulpe dentaire et thérapeutique d'apexification comprenant un inhibiteur de la prolyl-hydroxylase ou un inhibiteur de l'histone désacétylase et des antibiotiques, et réseau de nanofibres de polymères synthétiques comprenant la composition |
CN107307914A (zh) * | 2017-08-09 | 2017-11-03 | 张迎春 | 一种口腔临床用于牙髓腔减压暂封膜 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2644232A (en) * | 1950-03-25 | 1953-07-07 | Vahe S Roubian | Insulating and medicinal pad for dental cavities |
DE953831C (de) * | 1954-04-25 | 1956-12-06 | Dr Julius Walser | Einrichtung zur Aufbewahrung und Entnahme von Isolierschichten zum Schutz der Pulpa gegen thermische und chemische Reize durch Zahnfuellungen |
DE9317896U1 (de) * | 1993-06-09 | 1994-03-03 | Gottschall, Peter, 88524 Uttenweiler | Instrument zum Handhaben eines Zahninlays |
DE29521058U1 (de) * | 1995-05-22 | 1996-08-14 | Schumacher, Dieter, 24768 Rendsburg | Kalottenförmige Inlays |
DE29608674U1 (de) * | 1996-05-14 | 1996-08-08 | Schmidt, Birgit, 47229 Duisburg | Provisorische Zahnfüllung |
DE19948787A1 (de) | 1999-06-10 | 2001-01-25 | Domonkos Horvath | Medizinische Membran zur Anregung der Gewebebildung |
-
2000
- 2000-05-31 AU AU46055/00A patent/AU4605500A/en not_active Abandoned
- 2000-05-31 WO PCT/IB2000/000730 patent/WO2000076418A1/fr not_active Application Discontinuation
- 2000-05-31 EP EP00927670A patent/EP1185212A1/fr not_active Withdrawn
- 2000-05-31 CA CA002376328A patent/CA2376328A1/fr not_active Abandoned
- 2000-05-31 JP JP2001502761A patent/JP2003501201A/ja active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO0076418A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2376328A1 (fr) | 2000-12-21 |
AU4605500A (en) | 2001-01-02 |
JP2003501201A (ja) | 2003-01-14 |
WO2000076418A1 (fr) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0609738B1 (fr) | Dispositif de recouvrement pour cavité osseuse | |
DE69018457T2 (de) | Gegenstände zur behandlung von periodontitis und knochendefekten. | |
DE68913556T2 (de) | Chirurgische grenzschicht. | |
DE69331108T2 (de) | Systeme zum einpflanzen von gefässbildendem gewebe | |
EP0809979B2 (fr) | Feuille pour recouvrir des emplacements de défauts osseux et procédé de fabrication de la feuille | |
DE69329334T2 (de) | Systeme für die implantierung von zellen | |
DE69923167T2 (de) | Membran mit gewellter Oberfläche zur Führung des Gewebes | |
DE2733394C3 (de) | Kunstzahn mit implantierbarer Zahnwurzel | |
DE2928007A1 (de) | Knochen-implantatkoerper fuer prothesen und knochenverbindungsstuecke sowie verfahren zu seiner herstellung | |
DE10357579A1 (de) | Implantat mit einem Hautdurchtrittsabschnitt | |
EP1530446A1 (fr) | Implant a implanter dans un tissu osseux ou dans un tissu osseux comble par un materiau de substitution osseuse | |
EP0934750A2 (fr) | Remplacement bio-hybride de surface d'articulation | |
EP2249739B1 (fr) | Implant résorbable destiné à être introduit dans une cavité alvéolaire | |
EP0893975A1 (fr) | Implant dentaire | |
DE2507933A1 (de) | Zahnheilmittel | |
EP1301141A1 (fr) | Dispositifs et membranes medicales pour la regeneration osseuse | |
DE3704089A1 (de) | Heterologes implantat | |
DE68906856T2 (de) | Perkutanes Implantat. | |
EP3979944A1 (fr) | Implant dentaire présentant différentes rugosités de surface | |
EP0468518B1 (fr) | Utilisation de ciment ionomère-verre pour la régénération assisteé de tissu | |
EP1053758A1 (fr) | Implant bioabsorbable | |
EP1185212A1 (fr) | Membrane a usage medical pour stimuler la formation tissulaire | |
DE19648876C2 (de) | Verfahren zum Herstellen eines natürlichen Implantats | |
DE102011075808B4 (de) | Implantat zur Anwendung bei einer photo-dynamischen Behandlung sowie Verfahren zur Herstellung des Implantats | |
DE19948787A1 (de) | Medizinische Membran zur Anregung der Gewebebildung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20040820 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HORVATH, DOMONKOS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20041231 |